BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,812,000 | -65.2% | 35,867 | -56.0% | 0.07% | -59.4% |
Q1 2022 | $5,203,000 | -50.4% | 81,444 | -16.8% | 0.18% | -47.6% |
Q4 2021 | $10,488,000 | +3.1% | 97,916 | -1.0% | 0.33% | -4.0% |
Q3 2021 | $10,172,000 | +36.6% | 98,939 | +16.9% | 0.35% | +35.4% |
Q2 2021 | $7,445,000 | +993.2% | 84,645 | +1109.2% | 0.26% | +928.0% |
Q1 2021 | $681,000 | – | 7,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |